Citations

Showing 10 of 108119 citations.

Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).
Bernath, Albert M., Northfelt, Donald W. , Hou, Xiaonan , Tenner, Kathleen , Tienchaiananda, Piyawan , Flickinger, Lynn M. , Chen, Beiyun, Chen, Helen X., Lingle, Wilma L., Pellegrino, Christine, Sponzo, Robert W., Reinholz, Monica M., Perez, Edith A. , Haluska, Paul , Ballman, Karla V. , Dueck, Amylou C. , Linden, Hannah M. , Goetz, Matthew P.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 632-632

10.1200/jco.2014.32.15_suppl.632 Get It

Identification and targeting of M-phase progression downstream of HER2 in trastuzumab-sensitive and -resistant breast cancer cell lines.
Thompson, E. Aubrey , Necela, Brian M. , Carr, Jennifer M., Kachergus, Jennifer M., Serie, Daniel, Asmann, Yan W. , Perez, Edith A. , Kalari, Krishna R.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 612-612

10.1200/jco.2014.32.15_suppl.612 Get It

Genes associated with serum estrone, estrone conjugates, and androstenedione concentrations in postmenopausal women with estrogen receptor-positive breast cancer.
Dudenkov, Tanda M., Buzdar, Aman U. , Kubo, Michiaki , Batzler, Anthony , Jenkins, Gregory D. , Pietrzak, Tracy L., Northfelt, Donald W. , Perez, Edith A. , Williard, Clark, Nakamura, Yusuke , Wang, Liewei , Weinshilboum, Richard M. , Ingle, James N. , Robson, Mark E. , Carlson, Erin E. , Fridley, Brooke L. , Goetz, Matthew P. , Kalari, Krishna R. , Weinshilboum, Richard M.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 593-593

10.1200/jco.2014.32.15_suppl.593 Get It

Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial.
Perez, Edith A. , Thompson, E. Aubrey , Anderson, S. Keith , Asmann, Yan W. , Eckel‐Passow, Jeanette E. , Tenner, Kathleen , Jen, Jin , Fan, Jian‐Bing , Geiger, Xochiquetzal J., McCullough, Ann E. , Chen, Beiyun, Zschunke, Michael A., Jenkins, Robert B. , Reinholz, Monica M., Kalari, Krishna R. , Dueck, Amylou C. , Sledge, George W. , Winer, Eric P. , Gralow, Julie R. , Ballman, Karla V.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 509-509

10.1200/jco.2014.32.15_suppl.509 Get It

Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103.
O’Neill, Anne, Dang, Chau T. , Northfelt, Donald W. , Gradishar, William J. , Goldstein, Lori J. , Brufsky, Adam , Bloom, Stuart H. , Fox, Kevin R., Hendricks, Carolyn B., Balcueva, Ernie, Brufsky, Adam M , Miller, Kathy D. , Mayer, Ingrid A. , Sparano, Joseph A. , Tevaarwerk, Amyé , Sledge, George W.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 500-500

10.1200/jco.2014.32.15_suppl.500 Get It

TBCRC 022: Phase II trial of neratinib for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer and brain metastases (BCBM).
Gelman, Rebecca , Krop, Ian E. , Melisko, Michelle , Agar, Nathalie Y.R. , Blackwell, Kimberly , Connolly, Roisín M. , Poznak, Catherine Van , Puhalla, Shannon, Ryabin, Nicole, Lawler, Elizabeth S, Ibrahim, Nuhad K. , Liu, Minetta C. , Agar, Nathalie Y R , Freedman, Rachel A. , Wefel, Jeffrey S. , Lowe, Alarice Cheng-Yi , Niravath, Polly Ann , Wolff, Antonio C. , Winer, Eric P. , Lin, Nancy U.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 528-528

10.1200/jco.2014.32.15_suppl.528 Get It

Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact.
Wiktor, Anne E., Meyer, Reid G., Tenner, Kathleen , Perez, Edith A. , Jenkins, Robert B. , Shah, Meera , Ballman, Karla V. , Ketterling, Rhett P.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 523-523

10.1200/jco.2014.32.15_suppl.523 Get It

First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-posi
Piccart, Martine , Holmes, Andrew , Baselga, José , Viale, Giuseppe , Zujewski, Jo Anne , Goldhirsch, Aron, Jackisch, Christian , Láng, István, Smith, Ian E., Boyle, Frances , Gelber, Richard D. , Perez, Edith A. , Azambuja, Evandro de , Dueck, Amylou C. , Zujewski, Jo Anne , Santillana, Sergio, Pritchard, Kathleen I. , Wolff, Antonio C. , Untch, Michael , Xu, Binghe , Gómez, Henry

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA4-LBA4

10.1200/jco.2014.32.15_suppl.lba4 Get It

CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rec
Lenz, Heinz‐Josef , Innocenti, Federico , Mahoney, Michelle R., O’Neil, Bert H. , Polite, Blasé N. , Höchster, Howard S. , Atkins, James N., Goldberg, Richard M. , Schilsky, Richard L. , Blanke, Charles D. , ECOG, Cancer and Leukemia Group B (Alliance), SWOG, and, Venook, Alan P. , Niedzwiecki, Donna , Shaw, James Edward , Mayer, Robert J. , Bertagnolli, Monica M. , ECOG, Cancer and Leukemia Group B (Alliance), SWOG, and

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA3-LBA3

10.1200/jco.2014.32.15_suppl.lba3 Get It

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
Sweeney, Christopher, Liu, Glenn , Jarrard, David Frasier, Eisenberger, Mario A. , Wong, Yu‐Ning, Hahn, Noah M. , Cooney, Matthew M. , Shevrin, Daniel H. , García, Jorge A. , DiPaola, Robert S. , Chen, Yu‐Hui , Carducci, Michael A. , Kohli, Manish , Vogelzang, Nicholas J. , Dreicer, Robert , Picus, Joel , Hussain, Maha

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA2-LBA2

10.1200/jco.2014.32.15_suppl.lba2 Get It